124 related articles for article (PubMed ID: 29019266)
1. Liposome-loaded thermo-sensitive hydrogel for stabilization of SN-38 via intratumoral injection: optimization, characterization, and antitumor activity.
Bai R; Deng X; Wu Q; Cao X; Ye T; Wang S
Pharm Dev Technol; 2018 Jan; 23(1):106-115. PubMed ID: 29019266
[TBL] [Abstract][Full Text] [Related]
2. Thermosensitive Hydrogel System With Paclitaxel Liposomes Used in Localized Drug Delivery System for In Situ Treatment of Tumor: Better Antitumor Efficacy and Lower Toxicity.
Mao Y; Li X; Chen G; Wang S
J Pharm Sci; 2016 Jan; 105(1):194-204. PubMed ID: 26580704
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes.
Chen M; Li W; Zhang X; Dong Y; Hua Y; Zhang H; Gao J; Zhao L; Li Y; Zheng A
Int J Nanomedicine; 2017; 12():5487-5500. PubMed ID: 28814865
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
[TBL] [Abstract][Full Text] [Related]
5. Spatial distribution and antitumor activities after intratumoral injection of fragmented fibers with loaded hydroxycamptothecin.
Wei J; Luo X; Chen M; Lu J; Li X
Acta Biomater; 2015 Sep; 23():189-200. PubMed ID: 26013039
[TBL] [Abstract][Full Text] [Related]
6. Preparation of irinotecan-loaded folate-targeted liposome for tumor targeting delivery and its antitumor activity.
Zhang Z; Yao J
AAPS PharmSciTech; 2012 Sep; 13(3):802-10. PubMed ID: 22639238
[TBL] [Abstract][Full Text] [Related]
7. SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study.
Fang YP; Chuang CH; Wu YJ; Lin HC; Lu YC
Int J Nanomedicine; 2018; 13():2789-2802. PubMed ID: 29785106
[TBL] [Abstract][Full Text] [Related]
8. 7-Ethyl-10-hydroxycamptothecin proliposomes with a novel preparation method: optimized formulation, characterization and in-vivo evaluation.
Wang S; Ye T; Yang B; Yi X; Yao H
Drug Dev Ind Pharm; 2013 Feb; 39(2):393-401. PubMed ID: 22583043
[TBL] [Abstract][Full Text] [Related]
9. Preparation of pegylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in mice.
Atyabi F; Farkhondehfai A; Esmaeili F; Dinarvand R
Acta Pharm; 2009 Jun; 59(2):133-44. PubMed ID: 19564139
[TBL] [Abstract][Full Text] [Related]
10. Injectable SN-38-loaded Polymeric Depots for Cancer Chemotherapy of Glioblastoma Multiforme.
Manaspon C; Nasongkla N; Chaimongkolnukul K; Nittayacharn P; Vejjasilpa K; Kengkoom K; Boongird A; Hongeng S
Pharm Res; 2016 Dec; 33(12):2891-2903. PubMed ID: 27495180
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of a novel liposome-based formulation of SN-38.
Zhang JA; Xuan T; Parmar M; Ma L; Ugwu S; Ali S; Ahmad I
Int J Pharm; 2004 Feb; 270(1-2):93-107. PubMed ID: 14726126
[TBL] [Abstract][Full Text] [Related]
12. Effective irinotecan (CPT-11)-containing liposomes: intraliposomal conversion to the active metabolite SN-38.
Sadzuka Y; Hirotsu S; Hirota S
Jpn J Cancer Res; 1999 Feb; 90(2):226-32. PubMed ID: 10189894
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of TNF-α after intratumoral injection using an in situ thermosensitive hydrogel.
Xu Y; Shen Y; Ouahab A; Li C; Xiong Y; Tu J
Drug Dev Ind Pharm; 2015 Mar; 41(3):369-74. PubMed ID: 24274583
[TBL] [Abstract][Full Text] [Related]
14. Antitumor efficacy and intratumoral distribution of SN-38 from polymeric depots in brain tumor model.
Vejjasilpa K; Nasongkla N; Manaspon C; Larbcharoensub N; Boongird A; Hongeng S; Israsena N
Exp Biol Med (Maywood); 2015 Dec; 240(12):1640-7. PubMed ID: 26080460
[TBL] [Abstract][Full Text] [Related]
15. [Preparation and characterization of 7-ethyl-10-hydroxycamptothecin-loaded hypomicron of amphiphilic block copolymer].
Wu QL; Luan LB
Yao Xue Xue Bao; 2007 Apr; 42(4):440-4. PubMed ID: 17633216
[TBL] [Abstract][Full Text] [Related]
16. pH-dependent association of SN-38 with lipid bilayers of a novel liposomal formulation.
Peikov V; Ugwu S; Parmar M; Zhang A; Ahmad I
Int J Pharm; 2005 Aug; 299(1-2):92-9. PubMed ID: 15996839
[TBL] [Abstract][Full Text] [Related]
17. Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.
Stano P; Bufali S; Pisano C; Bucci F; Barbarino M; Santaniello M; Carminati P; Luisi PL
J Liposome Res; 2004; 14(1-2):87-109. PubMed ID: 15461935
[TBL] [Abstract][Full Text] [Related]
18. Fabrication of biodegradable micelles with sheddable poly(ethylene glycol) shells as the carrier of 7-ethyl-10-hydroxy-camptothecin.
Guo Q; Luo P; Luo Y; Du F; Lu W; Liu S; Huang J; Yu J
Colloids Surf B Biointerfaces; 2012 Dec; 100():138-45. PubMed ID: 22766290
[TBL] [Abstract][Full Text] [Related]
19. A reconstituted thermosensitive hydrogel system based on paclitaxel-loaded amphiphilic copolymer nanoparticles and antitumor efficacy.
Liang Y; Dong C; Zhang J; Deng L; Dong A
Drug Dev Ind Pharm; 2017 Jun; 43(6):972-979. PubMed ID: 28121206
[TBL] [Abstract][Full Text] [Related]
20. Dual 7-ethyl-10-hydroxycamptothecin conjugated phospholipid prodrug assembled liposomes with in vitro anticancer effects.
Du Y; Zhang W; He R; Ismail M; Ling L; Yao C; Fu Z; Li X
Bioorg Med Chem; 2017 Jun; 25(12):3247-3258. PubMed ID: 28465086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
